Division of Nephrology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, United States.
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York, United States.
Physiol Rev. 2024 Jan 1;104(1):199-251. doi: 10.1152/physrev.00041.2022. Epub 2023 Jul 21.
The teleology of sex differences has been argued since at least as early as Aristotle's controversial more than 300 years BC, which reflects the sex bias of the time to contemporary readers. Although the question "why are the sexes different" remains a topic of debate in the present day in metaphysics, the recent emphasis on sex comparison in research studies has led to the question "how are the sexes different" being addressed in health science through numerous observational studies in both health and disease susceptibility, including blood pressure regulation and hypertension. These efforts have resulted in better understanding of differences in males and females at the molecular level that partially explain their differences in vascular function and renal sodium handling and hence blood pressure and the consequential cardiovascular and kidney disease risks in hypertension. This review focuses on clinical studies comparing differences between men and women in blood pressure over the life span and response to dietary sodium and highlights experimental models investigating sexual dimorphism in the renin-angiotensin-aldosterone, vascular, sympathetic nervous, and immune systems, endothelin, the major renal sodium transporters/exchangers/channels, and the impact of sex hormones on these systems in blood pressure homeostasis. Understanding the mechanisms governing sex differences in blood pressure regulation could guide novel therapeutic approaches in a sex-specific manner to lower cardiovascular risks in hypertension and advance personalized medicine.
性别差异的目的论自亚里士多德(Aristotle)至少在公元前 300 多年极具争议的著作中就已经有了相关论述,这反映了当时的性别偏见,也让当代读者感到困惑。尽管“为什么性别不同”这个问题在今天的形而上学中仍然是一个争论的话题,但最近在研究中强调性别比较,已经促使健康科学领域通过大量针对健康和疾病易感性的观察性研究来探讨“性别差异的原因”,包括血压调节和高血压。这些努力使我们更好地了解了男性和女性在分子水平上的差异,部分解释了他们在血管功能和肾脏钠处理方面的差异,以及由此导致的高血压、心血管和肾脏疾病风险。这篇综述主要关注比较男性和女性在整个生命周期中的血压差异以及对膳食钠的反应的临床研究,并强调了研究肾素-血管紧张素-醛固酮、血管、交感神经系统和免疫系统、内皮素、主要肾脏钠转运体/交换体/通道的性别二态性以及性激素对这些系统在血压稳态中的影响的实验模型。了解控制血压调节性别差异的机制,可以以性别特异性的方式指导新的治疗方法,降低高血压患者的心血管风险,并推进个性化医疗。
Am J Physiol Renal Physiol. 2020-2-10
Am J Physiol Renal Physiol. 2025-3-1
Int J Mol Sci. 2024-8-8
Curr Hypertens Rep. 2018-6-8
Comput Biol Med. 2018-11-10
Am J Physiol Renal Physiol. 2024-5-1
Hypertension. 2022-7
Alzheimers Dement. 2025-8
Diabetol Metab Syndr. 2025-7-22
Curr Hypertens Rep. 2025-6-10
Front Physiol. 2025-4-28
Physiol Rev. 2025-10-1
Int J Mol Sci. 2022-12-23
Am J Physiol Heart Circ Physiol. 2022-12-1
Am J Physiol Cell Physiol. 2022-11-1
Circ Res. 2022-5-13